Compare Nuvalent Inc (NUVL) vs Oxford Lane Capital Corp (OXLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Oxford Lane Capital Corp — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Oxford Lane Capital Corp trades at $8.82 (market cap $866.15M). The key difference: Nuvalent Inc is far larger — about 11.3× Oxford Lane Capital Corp's market cap, and Oxford Lane Capital Corp pays a 27.06% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | OXLC | |
|---|---|---|
Market Cap | $9.81B | $866.15M |
Sector | Technology | Financials |
52-Week High | $123.96 | $19.90 |
52-Week Low | $72.16 | $8.15 |
Enterprise Value | $8.52B | — |
Dividend Yield | — | 27.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Oxford Lane Capital Corp
Oxford Lane Capital Corp. is a non-diversified, closed-end management investment company. Its primary investment objective is to achieve high current income, with a secondary objective of capital appreciation. The company primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs), which are pools of corporate loans. OXLC is known for its high-yield distribution policy and provides investors with leveraged exposure to the CLO market.
Read more on OXLC →
